EUVIMEDEUVIMED entdecken
Crossref

Performance evaluation of a novel high-sensitivity cardiac troponin T assay: analytical and clinical perspectives

Zhongxin Li, Shuo Yang, Jiao Qiao, Yuan Tan, Qi Liu, Boxin Yang, Weimin Feng, Liyan Cui

Clinical Chemistry and Laboratory Medicine (CCLM) · 2024

DOI: 10.1515/cclm-2023-0789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM), 2024. Verfasst von Zhongxin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Peking University Third Hospital, Beijing, P.R. China. Hauptthemen laut MEDLINE: Myocardial Infarction, Non-ST Elevated Myocardial Infarction, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Key Clinical Specialty Funding Project of Beijing, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the analytical characteristics of a novel high-sensitivity cardiac troponin T (hs-cTnT) test on the automatic light-initiated chemiluminescent assay (LiCA ® ) system, and validated its diagnostic performance for non-ST-segment elevation myocardial infarction (NSTEMI).

Methods

Studies included an extensive analytical evaluation and established the 99th percentile upper reference limit (URL) from apparently healthy individuals, followed by a diagnostic performance validation for NSTEMI.

Results

Sex-specific 99th percentile URLs were 16.0 ng/L (1.7 % CV: coefficient of variation) for men (21–92 years) and 13.4 ng/L (2.0 % CV) for women (23–87 years) in serum, and 30.6 ng/L (0.9 % CV) for men (18–87 years) and 20.2 ng/L (1.4 % CV) for women (18–88 years) in heparin plasma. Detection rates in healthy individuals ranged from 98.9 to 100 %. An excellent agreement was identified between LiCA ® and Elecsys ® assays with a correlation coefficient of 0.993 and mean bias of −0.7 % (−1.8–0.4 %) across the full measuring range, while the correlation coefficient and overall bias were 0.967 and −1.1 % (−2.5–0.3 %) for the lower levels of cTnT (10–100 ng/L), respectively. At the specific medical decision levels (14.0 and 52.0 ng/L), assay difference was estimated to be

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionNon-ST Elevated Myocardial InfarctionST Elevation Myocardial InfarctionMaleHumansFemaleTroponin THeparinSensitivity and SpecificityBiomarkers

Stichwörter der Autor:innen

cardiac troponin Thigh-sensitivitylight-initiated chemiluminescent assayperformance evaluation

Substanzen

Troponin THeparinBiomarkers

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Peking University Third Hospital, Beijing, P.R. China.

Förderung

  • Key Clinical Specialty Funding Project of Beijing
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Li, Z., Yang, S., Qiao, J., Tan, Y., Liu, Q., Yang, B., Feng, W., & Cui, L. (2024). Performance evaluation of a novel high-sensitivity cardiac troponin T assay: analytical and clinical perspectives. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2023-0789

Vancouver

Li Z, Yang S, Qiao J, Tan Y, Liu Q, Yang B, et al. Performance evaluation of a novel high-sensitivity cardiac troponin T assay: analytical and clinical perspectives. Clinical Chemistry and Laboratory Medicine (CCLM). 2024. doi:10.1515/cclm-2023-0789

BibTeX
@article{Li2024,
  author = {Li, Zhongxin and Yang, Shuo and Qiao, Jiao and Tan, Yuan and Liu, Qi and Yang, Boxin and Feng, Weimin and Cui, Liyan},
  title = {Performance evaluation of a novel high-sensitivity cardiac troponin T assay: analytical and clinical perspectives},
  journal = {Clinical Chemistry and Laboratory Medicine (CCLM)},
  year = {2024},
  doi = {10.1515/cclm-2023-0789}
}
Kostenlos starten →